|
|
|
|
|
|
|
Wave Life Sci Ord Sh (WVE)
|
|
43.5 1.5 (3.57%)
|
04-20 16:00
|
|
Open:
|
42
|
Pre. Close:
|
42
|
|
High:
|
43.75
|
Low:
|
42
|
|
Volume:
|
107,926
|
Market Cap:
|
1265M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
43.799 - 43.973
|
43.973 - 44.123
|
|
Low:
|
41.528 - 41.739
|
41.739 - 41.92
|
|
Close:
|
43.129 - 43.479
|
43.479 - 43.781
|
|
|
|
Technical analysis (as of: 2018-04-20 4:34:55 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 54.25 One year: 63.37
|
|
Support:
|
Support1: 40.98 Support2: 37.60
|
|
Resistance:
|
Resistance1:
46.45 Resistance2: 54.25
|
|
Pivot:
|
41.80
|
|
Moving Averages:
|
MA(5): 42.17 MA(20): 41.25
MA(100): 40.65 MA(250): 29.16
|
|
MACD:
|
MACD(12,26):
-0.11 Signal(12,26,9): -0.43
|
|
%K %D:
|
%K(14,3): 54.80 %D(3): 50.65
|
|
RSI:
|
RSI(14): 54.71
|
|
52-Week:
|
High: 55.95
Low: 15.15 Change(%): 114.8
|
|
Average Vol(K):
|
3-Month: 16423
10-Days 14191
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.WVE has closed below upper band by 16.3%. Bollinger Bands are 48.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to WVE's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-04-12T09:15:11-04:00
Dosing underway in early-stage study of Pfizer's DMD candidate
2018-04-10T11:10:46-04:00
Wave Life Sciences teams up with Deep Genomics to develop neuromuscular therapies; shares up 2%
2018-04-04T11:14:00-04:00
Oryzon Genomics on go with mid-stage study of Alzheimer's candidate ORY-2001
2018-03-12T08:03:04-04:00
Wave Life Sciences misses by $0.15, beats on revenue
2018-02-21T11:49:59-05:00
Your Daily Pharma Scoop: Portola Update, Wave Life Sciences To Collaborate With Takeda, AbbVie Reports Data For Egolix
2018-02-21T02:42:33-05:00
U.S. Biotech/Pharma Sector Daily Observations Letter: February 20, 2018
2018-02-20T12:47:14-05:00
Midday Gainers / Losers (2/20/2018)
2018-02-20T12:12:39-05:00
Wave Life Sciences teams up with Takeda to develop CNS treatments
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
